Min Liang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 21

Top Topics

Endothelial Cells

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Author Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Rena Baek, Kimberly Coughlan, Lei Jiang, Min Liang, Lei Ci, Harkewal Singh, Hannah Zhang, Neeraj Kaushal, Ivana Liric Rajlic, Linh Van, Rain Dimen, Alexander Cavedon, Ling Yin, Lisa Rice, Andrea Frassetto, Lin Guey, Patrick F Finn, Paolo G V Martini
Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria. Nature communications 15 (1) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Rena Baek, Kimberly Coughlan, Lei Jiang, Min Liang, Lei Ci, Harkewal Singh, Hannah Zhang, Neeraj Kaushal, Ivana Liric Rajlic, Linh Van, Rain Dimen, Alexander Cavedon, Ling Yin, Lisa Rice, Andrea Frassetto, Lin Guey, Patrick F Finn, Paolo G V Martini
Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria. Nature communications 15 (1) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Rena Baek, Kimberly Coughlan, Lei Jiang, Min Liang, Lei Ci, Harkewal Singh, Hannah Zhang, Neeraj Kaushal, Ivana Liric Rajlic, Linh Van, Rain Dimen, Alexander Cavedon, Ling Yin, Lisa Rice, Andrea Frassetto, Lin Guey, Patrick F Finn, Paolo G V Martini
Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria. Nature communications 15 (1) (2024)